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Available online 27 November 2015Background: An estimated 100,000 cases of congenital rubella syndrome (CRS) occur worldwide each year. The
reported mortality rate for infants with CRS is up to 33%. The cellular mechanisms responsible for the multiple
congenital defects in CRS are presently unknown. Here we identify cell types positive for rubella virus (RV) in
CRS infants.
Methods: Cells and organs involved in RV replication were identiﬁed in parafﬁn-embedded autopsy tissues from
three fatal case-patients by histopathologic examination and immunohistochemical (IHC) staining using a rabbit
polyclonal RV antibody. Normal rabbit antisera and RV antisera preabsorbed with highly puriﬁed RV served as neg-
ative controls.
Results: RV antigen was found in interstitial ﬁbroblasts in the heart, adventitial ﬁbroblasts of large blood vessels, al-
veolarmacrophages, progenitor cells of the outer granular layer of the brain, and in capillary endothelium and basal
plate in the placenta. The antibody speciﬁcity was veriﬁed by IHC staining of multiple tissue sections from other in-
fectious disease cases. RV infection of each cell type is consistent with abnormalities which have been identiﬁed in
patientswithCRS, in theheart, large blood vessels, andbrain. Antigendistributionwas consistentwith inﬂammatory
response to vascular injury and systemic spread of RV.
Conclusions: The identiﬁcation of RV positive cell types in CRS is important to better understand the pathology and
pathogenesis of CRS.
Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Autopsy1. Introduction
Rubella virus (RV) is an enveloped, positive-sense, single-stranded
RNA virus of the genus Rubivirus, the family Togaviridae. Congenital ru-
bella syndrome (CRS) is a serious disease caused by RV infection in
utero (Plotkin et al., 2011). During the period of maternal viremia, RV
may infect the placenta, pass the placental barrier and enter the fetal
bloodstream, possibly through emboli of necrotic endothelial cells orig-
inating from infected chorion (Tondury and Smith, 1966; Driscoll, 1969;
Ornoy et al., 1973; Lima et al., 1977). If the fetus is infected during the
ﬁrst trimester of pregnancy, the virus usually persists until term inmul-
tiple fetal organs causing a spectrum of birth defects that includesand Prevention, 1600 Clifton Rd
ss article under the CC BY-NC-ND lichearing impairment, and ocular and cardiovascular abnormalities
(Rawls, 1968; Singer et al., 1967; Esterly and Oppenheimer, 1973).
Birth defects in individual cases can be minor or severe, affecting
many organs or only a few (Lindquist et al., 1965; Rosenberg et al.,
1981). Gestational age at the time of maternal infection is the most im-
portant determinant of fetal damage. The risk of fetal infectionwith con-
genital anomalies is highest during the ﬁrst 11–12 weeks of gestation,
but then sharply decreases with increasing gestational age (Alford
et al., 1964; Sheridan, 1964; Miller et al., 1982). Fetal infection after
16 weeks of gestation typically results in an infant without clinical
signs of CRS and such cases are classiﬁed as congenital rubella infection
(CRI) if laboratory conﬁrmed by IgM ELISA or virus detection.
A signiﬁcant non-CRS manifestation of in utero rubella virus infec-
tion is spontaneous abortionwhich occurs in about 20% of rubella infec-
tions acquired during pregnancy. The limited fetal damage after the ﬁrst
trimester is presumably because organogenesis is complete, maternal
IgG is transferred to the fetus, and a fetal immune response is present.
Late manifestations of CRS have also been recognized. Ocularense (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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recently been associated with Fuchs heterochromic iridocyclitis
(Winchester et al., 2013; de Groot-Mijnes et al., 2006). A rare disability
associated with CRS is progressive rubella panencephalitis (Townsend
et al., 1976). Another late onset disability is insulin-dependent diabetes
mellitus; in a follow-up study, 40% of CRS patients developed evidence
of overt or latent diabetes (Menser et al., 1974).
Children with CRS may be infectious for the entire ﬁrst year of life,
rarely even longer (Cooper and Krugman, 1967; Rawls et al., 1967), and
can transmit the virus causing infection in non-immune individuals
(Hardy et al., 1965; Greaves et al., 1982; Schiff and Dine, 1965). The infant
mortality rate for CRS can be as high as 33% (Cooper et al., 1965; Toizumi
et al., 2014). Disability-adjusted life years (DALY) lost per CRS casewas es-
timated to be between 19 and 38 depending on the country income and
health care resources (Simons et al., 2014). Rubella and CRS are rare in
most developed countries but are still a signiﬁcant risk for non-immune
pregnant women in developing regions and an estimated 100,000 CRS
cases occur worldwide each year (Cutts and Vynnycky, 1999). In the ab-
sence of vaccination, rubella is an endemic disease with epidemics
every 6 to 9 years (Horstmann, 1971).
The pathology of CRS was comprehensively documented following
themajor rubella pandemic in 1963–1965. Histopathologic investigations
of fetal CRS cases revealed tissue damage in multiple fetal organs such as
the heart, blood vessels, crystalline lens, ears, brain, teeth, and liver
(Tondury and Smith, 1966; Driscoll, 1969; Esterly and Oppenheimer,
1969). Based on the localization of lesions, it was suggested that endothe-
lial cells, myocardial cells, skeletal muscle cells and particular epithelial
cells of the developing lens and inner ear were infected with RV
(Tondury and Smith, 1966). Only one study demonstrated the presence
of RV antigen in tissue sections of the heart and skeletalmuscle of a single
CRS case; each focus of RV infection involved only a few cells, whichwere
histologically entirely normal (Woods et al., 1966). However, modern
techniques and reagents should provide more precise identiﬁcation of
cell types infected byRV. A recent study of three aborted fetuseswith con-
genital rubella infection identiﬁed RV antigen in multiple organs, includ-
ing the lung, kidney, brain, spleen, heart and ciliary body (Nguyen et al.,
2015). Epithelial cells and mononuclear progenitor cells in multiple or-
gans and neuronal cells in cerebral cortex were reported to be the pre-
dominant cell types, in which RV capsid protein was detected by
immunohistochemical (IHC) staining. However, the precise cell types in
which RV replicates and persists in infants carried to term or born with
CRS have remained largely uncharacterized.
A nationwide rubella outbreak occurred in Romania in 2011–
2012 with more than 20,000 rubella cases in unvaccinated individ-
uals, and 22 laboratory conﬁrmed CRS cases, including ten deaths
and one stillbirth reported by the end of 2012 (Janta et al., 2012).
Rubella virus genotype 2B was associated with this outbreak
(unpublished data).
Here, we describe the clinical manifestations, laboratory investi-
gations, and histopathologic changes in formalin-ﬁxed, parafﬁn-
embedded (FFPE) tissue specimens obtained from three children with
fatal congenital rubella, and the application of an IHC assay for the detec-
tion and localization of rubella virus antigens. We assert implications of
the IHC results for CRS pathogenesis. These three cases were all carried
to or almost to term and thus this study describes RV antigen positive
cell types in CRS, rather than cells that were transiently infected during
pre-term pathogenesis.2. Materials and Methods
FFPE autopsy tissues of three CRS case-patients with serology or RT-
PCR conﬁrmed RV infection were submitted to the CDC for histopatho-
logic and immunohistopathologic evaluation. No other potential causes
of defects in these infants (e.g. environmental exposures or genetic mu-
tations) were noted.2.1. Clinical History and Tissue Samples
Case 1. Apremature girl (33 gestationweeks)was bornonNovember 13,
2012. The course of pregnancy was not medically supervised. The APGAR
(Appearance, Pulse, Grimace, Activity, Respiration) score was 7 at 1 min
and 9 at 5 min after birth. Scores of 7 and above indicate that a newborn
is healthy and does not require immediatemedical interventions. The girl
weighed 2050 g andhadpulmonary hypertension. CRS diagnosiswas lab-
oratory conﬁrmed by a positive test for rubella immunoglobulin M (IgM
ELISA) from serum collected on the 24th day of life. She died after
96 days. Immunological tests were negative for other teratogenic patho-
gens (cytomegalovirus (CMV), mycoplasma pneumonia, and herpes sim-
plex virus (HSV) types 1 and 2). Examination and autopsy revealed
bilateral congenital cataracts, liver dystrophy, cardiomegaly and multiple
cardiac anomalies including atrial septal defect, patent ductus arteriosus,
and patent foramen ovale. FFPE tissue samples were available from the
cerebral hemisphere, cerebellum, myocardium, aorta, lung, liver, pancre-
as, intestine, kidney, spleen and thymus.
Case 2. A girl (35 gestationweeks)was stillborn onNovember 23, 2012.
Themother was serologically conﬁrmed (IgM ELISA) to have had rubel-
la in the ﬁrst trimester of pregnancy (week 13). Autopsy revealed a
globular heart with a single atrium, primary pulmonary atelectasis,
and cerebral edema. FFPE blockswere prepared from theplacenta,myo-
cardium, liver, lung, spleen, kidney, and umbilical cord. Note that CRS is
by deﬁnition a syndromewhichmust be found in a live infant. We have
considered this term stillbirth a CRS case for the purposes of this study.
Case 3. A boy was born on December 12, 2012 after 39 weeks gestation
period having birthweight of 1160 g, consistentwith small for gestational
age. APGAR score was 4 at 5 min. The course of pregnancy for this case
was not medically supervised. The clinical signs included respiratory dis-
tress, congenital pneumonia, cataract, glaucoma, hearing loss, congenital
heart disease, patent ductus arteriosus, splenomegaly, microcephaly, de-
velopmental delay, radiolucent bone disease, and jaundice within 24 h.
Serum and nasopharyngeal swab were collected 5 days after the birth.
The serum was IgM-positive and rubella virus was detected in nasopha-
ryngeal swab by real-time RT-PCR. The baby died when 21 days old
after cardiorespiratory failure. FFPE blocks from the liver, lung, kidney,
spleen, pulmonary artery, brain, and skeletal muscle were available.2.2. ELISA
The detection of rubella IgM was performed using Enzygnost Anti-
Rubella Virus/IgM kit (Siemens Healthcare Diagnostics Products
GmbH) and Rubella virus IgM micro-capture kit (IBL International).2.3. PCR
Fresh tissue samples from the lung, kidney, spleen, lens, liver, brain,
thymus, and heart were collected only for Case 3. All tested samples
were positive by real-time RT-PCR assay, which was previously de-
scribed in detail (Abernathy et al., 2009) using the SuperScript™ III
Platinum® One-Step Quantitative RT-PCR System (Invitrogen, United
States). Skeletal muscle and myocardium samples were negative. Sub-
sequent genotyping based on the standard genotyping window (nt
8731–9469)was performed by conventional RT-PCR reactions (QIAGEN
OneStep RT PCR Kit (QIAGEN, Hilden, Germany), using the protocol rec-
ommended by theGlobalMeasles andRubella Laboratory Networkwith
minor modiﬁcations (Standardization of the nomenclature for genetic
characteristics of wild-type rubella viruses, 2005; Namuwulya et al.,
2014). For sequencing PRISM BigDye Terminator v3.1 Ready Reaction
Cycle Sequencing kit was used (Applied Biosystems, Foster City, Califor-
nia) and sequences were determined on a PRISM 3100-Avant Genetic
88 M. Lazar et al. / EBioMedicine 3 (2016) 86–92Analyzer (Applied Biosystems, Foster City, California). The genotype of
rubella virus was identiﬁed as 2B (GenBank Acc. # KR021370).
2.4. Antibodies
Rabbit polyclonal anti-rubella antibodywas raised against puriﬁed ru-
bella virions (strainHPV77,Meridian Life Science) by theCDCcore facility.
The speciﬁcity of the antibody was documented with Western blotting
and immunoﬂuorescence assays using RV infected and mock infected
cell cultures (data not shown) and veriﬁed immunohistochemically by
testing the antibody against cases or cell controls positive for other infec-
tions associated with congenital abnormalities (Toxoplasma gondii, vari-
cella zoster virus, parvovirus B19, CMV, HSV-1) and measles virus.
2.5. Histopathology and Immunohistochemistry
Hematoxylin–eosin (H&E) staining was performed for histopatho-
logical evaluation. The IHC assay for RV antigen was performed on 3-
μm sections of FFPE tissues. Deparafﬁnized and rehydrated tissue sec-
tions were placed in a LAB Vision autostainer and digested in 0.1 mg/
ml proteinase K (Roche Diagnostics GmbH Mannheim, Germany). The
staining process was done with a LabVision System on IntelliPATH
Autostainer 2× Secondary using UltraVision LPValue Large Volume De-
tection System AP Polymer kit (Thermo Scientiﬁc, UK) according to the
kit instructions. Tissue sections were incubated with a rabbit anti-RV
polyclonal antibody for 30 min followed by sequential incubations
with enhancer, polymer and fast red substrate (Dako Corporation). Sec-
tionswere then counterstained inMeyer's hematoxylin (Fisher Scientif-
ic) using the Sakura Automatic Slide Stainer andmountedwith aqueous
mounting medium (Lerner Laboratories, Pittsburg, PA). The optimal di-
lution of the anti-rubella antibody for the IHC assay was determined
(1:500) by using a series of titrations applied to sections from FFPE
blocks with RV-infected A549 human lung carcinoma cells
(ATCC#CCL-185) mixed with normal human tissues, such sections
also served as a positive control in each IHC assay. Negative controls
were run in parallel and consisted of sequential tissue sections of case
patients each incubated with either normal rabbit serum or the rubella
antibody pre-absorbedwith puriﬁed rubella. Interpretation of IHC assay
results for rubella virus included determination of the location of theFig. 1. Pulmonary histopathologic and immunohistochemical features in a fatal CRS case (Case
and hyaline membrane formation. Diffuse alveolar damage and interstitial pneumonitis (b). Hi
veolar macrophages (d). Note immunostaining of globular inclusions.positive reaction in a cell (nuclear or cytoplasmic staining), the type of
cells infected and the intensity of staining.
3. Results
Histopathologic changes and IHC evidence for the presence of RV an-
tigens were documented in some organs from all cases.
3.1. Lung
Microscopic examination of all lungs from cases showed congestion,
intra-alveolar edema, and interstitial inﬂammation (Fig. 1a–c). The in-
ﬂammation was mild and consisted predominantly of mononuclear
cells. Histopathological changes of diffuse alveolar damage (DAD) in-
cluding edema, hyaline membranes, and inﬂammation were seen in
only one case (Case 1). Mild medial arterial hypertrophy was seen in
some vessels in Cases 1 and 2, however luminal vascular occlusion or ar-
terial thrombi were not identiﬁed. Immunohistochemical staining ex-
hibited viral antigens in alveolar macrophages. Globular aggregates of
rubella antigens were seen (Fig. 1d). In Cases 2 and 3, no signiﬁcant his-
topathologic ﬁndings were observed.
3.2. Heart
Morphologic myocardial damage in the CRS autopsy cases was not
signiﬁcant. In some areas the heart showed reactive myocytes with
plump nuclei and interstitial inﬂammation (Fig. 2a). No evidence of
myocarditis was observed in Case 2. Heart tissue was not available for
Case 3. Viral immunostaining was seen in ﬁbroblasts in Case 1 (Fig.
2b) and Case 2 (not shown).
3.3. Aorta and Pulmonary Artery
Multiple sections of the aorta (Fig. 3a) and pulmonary artery (not
shown) were examined and no morphological features were seen.
However, numerous ﬁbroblasts strongly positive for RV antigens were
detected in adventitia of aorta (Case 1) and in the pulmonary artery
(Case 3) (Fig. 3b).1). Low-power image of lung (a) shows congestion, edema, mild interstitial inﬂammation
gh-power image (c) shows intra-alveolar macrophages. Rubella virus antigens in intra-al-
Fig. 2. Cardiac histopathologic and immunohistochemical features in fatal cases of CRS. Higher-power magniﬁcation of the heart (a) showing reactive myocytes with plump nuclei and
focal inﬂammatory cells, but no clinically signiﬁcant inﬂammation (H&E staining). Abundant immunostaining of interstitial ﬁbroblasts (b).
Fig. 3.Aortic histopathologic and immunohistochemical features in a fatal case of CRS (Case 1). Low-powermagniﬁcation of the aorta (a) shows the lack of pathologic changes (H&E stain-
ing). Immunostaining of mesenchymal cells (between myocytes) and numerous ﬁbroblasts in a section of the aorta (b).
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Nohistopathological evidence of encephalitiswas observed in any of
case-patients with brain samples (Fig. 4a, c). Small areas of calciﬁcation
were observed. Focal staining of progenitor cells in the external granu-
lar cell layer was seen in the cerebellum of Case 1, but not in Case 3 (Fig.
4b, d).Fig. 4. Central nervous system histopathologic and immunohistochemical features in a fatal cas
ninges with no evidence of inﬂammation. Immunostaining of neuronal cells (c and d) in exter3.5. Placenta and Umbilical Cord
A placenta FFPE block was available only for Case 2. The chorionic
villi of the placenta were mature and with abundant blood vessels.
The decidua showed focal area of necrosis. No evidence of inﬂammation
was observed. Viral antigens were seen primarily in endothelial cells
(Fig. 5a, b) and the basal plate of the placenta (Fig. 5c).e of CRS (Case 1). Low-power (a) and high-power (b) images of the cerebellum showme-
nal granular cell layer of the cerebellum.
Fig. 5. Immunohistopathologic features in the placenta of Case 2. Low-power (a) and high-
power (b) images of sections of chorionic villi show immunostaining of endothelial cells.
(c) Section of the placenta (maternal plate) shows extracellular immunostaining through-
out the basal plate.
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Histopathological ﬁndings in other organs were nonspeciﬁc. The
liver in Case 1 showed diffuse small droplet macrovesicular steatosis
without signiﬁcant inﬂammation, while in Case 2 therewasmarked he-
patocyte swelling, cholestasis, congestion, and extramedullary hemato-
poiesis. Case 3 showedmid-zonal bridging necrosis, marked cholestasis
and scattered dystrophic calciﬁcations. No immunohistochemical RV
staining was identiﬁed in other organs.4. Discussion
This report presents histopathological and immunohistochemical
studies on autopsy samples from three fatal CRS patients that occurred
in 2012 in Romania. This study identiﬁed new target cells for rubella
virus in the tissues of these infants.One of the important ﬁndings was localization of RV antigen in car-
diac ﬁbroblasts in themyocardium of two patients and adventitia ﬁbro-
blasts of large blood vessels (aorta and pulmonary artery). Consistent
with descriptions of focal localization of lesions in cardiovascular tissues
(Tondury and Smith, 1966), RV antigen staining was found to be focal.
The one previous IHC study of an infant with CRS identiﬁed very com-
pact scattered foci of rubella infected cells in cardiac muscle ﬁbers
(Woods et al., 1966). In cases presented here we did not observe IHC
staining in cardiomyocytes. However, areas of histopathology involving
only a few cardiomyocyteswere often seennear IHCpositiveﬁbroblasts.
Perhaps the cases we studied had healed lesions after rubella virus was
cleared from cardiomyocytes. Cardiac ﬁbroblasts play a critical role in
development of the cardiovascular system andmaintaining normal car-
diac function, while adventitia ﬁbroblasts are important players in in-
ﬂammatory response to vascular injury (Deb and Ubil, 2014).
Infection of these cell types could have signiﬁcant involvement in the
congenital cardiovascular malformations seen in CRS patients.
Another novel ﬁnding was the identiﬁcation of RV antigen in pro-
genitor cells of outer granular layer of the brain. This cell type in the
brain of CRS patients has not been previously known to be infected
with rubella virus. However, the presence of unresolved outer granular
layer and underdeveloped internal granular layer in a CRS case has been
reported (Kemper et al., 1973). Mental retardation and microcephaly
are frequently seen in infants with congenital rubella syndrome. In
vitro studies suggested that the main cell type permissive to RV infec-
tion in developing brain tissue is the astrocyte (Chantler et al., 1995).
Pathology studies of the brain of infants with congenital rubella syn-
drome revealed extensive degenerative changes in leptomeningeal
and intrinsic arteries and veins of the cerebrum. Vascular damage was
associated with foci of necrosis localized in the deep white matter and
gray nuclei, but no developmental malformations or signiﬁcant inﬂam-
mation of the nervous systemwas found (Rorke and Spiro, 1967; Rorke,
1973). During CNS development, multipotent neural stem cells give rise
ﬁrst to various kinds of speciﬁed precursor cells, which proliferate ex-
tensively before terminally differentiating into either neurons or glial
cells. These progenitor cells migrate to different areas of the brain and
are involved in normal development of the CNS. Thus, RV infection of
progenitor cells could lead to a variety of malformations of the CNS,
such as those found in CRS patients.
Reports of congenital infection with other pathogens support the hy-
pothesis that immature cells are apt to be target cells for infection in the
developing brain (Feuer et al., 2003; Dietrich et al., 2004; Tsutsui et al.,
2008). HSV, CMV, toxoplasmosis, and other infections are potent dis-
rupters of fetal neurodevelopment leading to abnormalities in brain struc-
ture (e.g., hypoplasia of brain regions) and behavior disorders, including
mental retardation and learning disabilities (Brown and Derkits, 2010).
In a mouse model of fetal CMV infection neural stem progenitor cells in
developing brains are the cell type that is most susceptible to CMV infec-
tion. The resulting disturbance of cellular events such as proliferation, dif-
ferentiation and migration was suggested to be the main cause of CMV
brain disorders (Tsutsui et al., 2008). Further studies are necessary to de-
terminewhether RV infection of neural progenitor cells has any effects on
their proliferation, regeneration and differentiation.
The histopathologic changes of DAD were observed only in Case 1.
This infant had interstitial pneumonia and pulmonary hypertension,
which frequently occur in CRS cases (Singer et al., 1967; Boner et al.,
1983; Franklin and Kelley, 2001). Pulmonary arterial hypertension has
been recently identiﬁed as the major contributor to mortality in CRS
cases (Toizumi et al., 2014). We detected intense IHC staining in alveo-
larmacrophages.We did not observe staining of alveolar epithelial cells,
which were shown to be IHC positive in the rubella infected fetuses ex-
amined by Nguyen et al. (2015). Since RV infection in tissues is focal,
and RV antigen is typically detected in a limited number of cells, the
lack of immunostaining of alveolar epithelial cells in the present study
might simply be due to the absence of infected cells in those lung sec-
tions that we were able to analyze. Another possibility is RV infection
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cleared, but RV antigen was still present in alveolar macrophages. It is
currently unclear whether rubella virus replicates in macrophages.
This study also identiﬁed capillary endothelial cells and the basal
plate as the primary targets in the placenta. These data are in agreement
with the results of one large study of placentas from CRS cases, in which
rubella-speciﬁc immunoﬂuorescence was detected in epithelial cells of
chorionic blood vessels and amniotic epithelium; intracytoplasmic in-
clusion bodies (virions) were described in decidual cells in the basal
plate and cytotrophoblasts (Garcia et al., 1985). Infection of endothelial
cells can result in capillary necrosis and blockage of capillaries
impacting placenta functions and leading to growth retardation of the
fetus. Infection of endothelial cells may account for some of the vascular
anomalies and viral spread, whereas infection of cells in the basal plate
may lead to placental pathologies and thus account for themultitude of
congenital malformations in CRS patients.
One of the overall purposes of this work was to catalogue the cell
types with evidence of rubella infection in CRS cases. This study extends
the description of the pathology of CRS by IHC beyond the single previ-
ous report of RV infected cells in specimens from a single CRS case al-
most 50 years ago. A complimentary study to catalogue the cell types
with evidence of rubella infection from fetuses addressed which RV in-
fected cell types were found during the development of CRS (Nguyen
et al., 2015). The only RV positive cell type that was found in the study
of fetuses and the current study was neuronal cells. This is not unex-
pected because the positive cells during progression to CRS and the pos-
itive cells in CRS (term babies) may well be different due to transiently
infected cells during the progression to CRS. We expect that additional
studies of RV positive cell types in RV infected fetuses and in fatal CRS
cases will be necessary to fully describe and to understand the molecu-
lar pathogenesis and the pathology of CRS. However, as global elimina-
tion targets are met, opportunities to conduct such additional studies in
the future will diminish (Andrus et al., 2011).
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